AstraZeneca's core operating profit increased 5% to $1.67 billion. Excluding currency effects, core operating profit increased fell 2% and revenue declined 10%. "AstraZeneca Profit Drops on Decline in Blockbuster-Drug Revenue," at 0644 GMT, misstated the core operating profit as 2% in the second paragraph and that it increased 5% in the third paragraph.

(END) Dow Jones Newswires

April 27, 2017 03:40 ET (07:40 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Astrazeneca Charts.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Astrazeneca Charts.